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Abstract
Background: This study explored the association between inactive time and measures of adiposity, clinical
parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of
reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA)
on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and
blood pressure in older adults.
Methods: This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55–75 years, BMI
27–40 Kg/m2) from the PREDIMED-Plus study (http://www.predimedplus.com/). All participants had ≥3 components of
the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial
accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and
logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the
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relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of
adiposity and body composition, biochemical parameters and blood pressure in older adults.
Results: Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30min per day
of inactive time to 30min per day of time in bed was associated with lower BMI, waist circumference and glycated
hemoglobin (HbA1c) (all p-values < 0.05). Reallocating 30min per day of inactive time with 30min per day of LPA or
MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides,
and higher body muscle mass and HDL cholesterol (all p-values < 0.05).
Conclusions: Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time
with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Trial registration: The trial was registered at the International Standard Randomized Controlled Trial (ISRCTN: http://www.
isrctn.com/ISRCTN89898870) with number 89898870 and registration date of 24 July 2014, retrospectively registered.
Keywords: Inactive time, Light physical activity, Moderate to vigorous physical activity, Time in bed, Cardiometabolic risk,
Isotemporal substitution
Background
Cardio-metabolic diseases such as type 2 diabetes (T2D)
and the metabolic syndrome (MetS) are increasingly preva-
lent worldwide [1, 2]. Overweight and obesity are major risk
factors for these metabolic alterations [3–5] and the World
Health Organization (WHO) has projected a significant
increase by 2030 [1, 3, 6, 7]. A vast body of the literature
suggests that physical activity (PA) and sedentary behav-
iours, including inactive time and time in bed, are strongly
and independently associated with markers of obesity, body
composition, and the MetS [2, 8–20]. However, current
public health guidelines are mostly focused on the health
benefits of moderate-to-vigorous physical activity (MVPA)
and less attention is given to inactive time [21, 22].
Research in older adults highlights the health benefits of
MVPA and light physical activity (LPA) [2, 4, 23, 24].
However, limited research has explored the associations
between time spent inactive, time in bed and cardio-
metabolic health in an aging population [4, 13, 23, 25–28];
and, limited research has explored these associations at-
tending the 24-h finite time of a day in a population with
chronic conditions.
Isotemporal substitution models have been recommended
as one of the most appropriate statistical analysis to explore
the associations between reallocating activity patterns, par-
ticularly time spent inactive, and health outcomes [4, 13, 23,
26, 28–30]. This type of analyses takes into account that
time is finite. Thus, spending time in one behavior (ie. In-
active time) results in less time being spent in another (ie.
MVPA) [29], and understands that daily behaviours (sleep,
sedentarism and physical activity) are co-dependent [31].
This will provide insightful information that will help better
understand the impact of reallocating activity patterns in
cardio-metabolic markers in older adults. This is crucial for
the design of effective tailored interventions to improve car-
diometabolic health in older people in the future. Therefore,
this novel study aims to provide new evidence about the as-
sociations of inactive time with cardio-metabolic risk factors
in an aging population. The outcomes were markers of car-
diometabolic health: measures of adiposity and body com-
position, biochemical parameters, blood pressure, obesity,
type 2 diabetes and metabolic syndrome components. The
objectives of the present study were a) to explore cross-
sectional associations between inactive time and cardio-
metabolic risk factors; and b) to assess the impact of
replacing 30min per day of inactive time by 30min of LPA,
MVPA and time in bed on markers of cardio-metabolic
health.
Material and methods
Study overview and sample
The PREDIMED-Plus study is a 6-year ongoing multi-
center, randomized clinical trial, with two intervention
arms for the primary prevention of cardiovascular dis-
ease in Spain. Details of the study’s protocol have been
described elsewhere [32] and are available on the website
http://www.predimedplus.com/. Briefly, participant’s in
the intervention are receive a multicomponent weight
loss intervention that includes an energy-restricted trad-
itional Mediterranean Diet (erMedDiet), PA promotion
and behavioural support. Those in the control group
receive information about the Mediterranean Diet and
cardiovascular health guidelines only. The aim of the
study is to prevent cardiovascular disease (a composite
of cardiovascular death, non-fatal myocardial infarction,
and non-fatal stroke). Eligible participants were men
aged 55–75 and women aged 60–75 years, with body
mass index (BMI) ≥27 and < 40 kg/m2, who met ≥3 com-
ponents of the MetS [33]. Overall, 6874 men and women
were recruited and randomized into the study between
2013 and 2016 across 23 Spanish centers distributed
throughout the country’s geography; a subsample of
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2260 participants wore an accelerometer at baseline.
Participants were asked to wear the accelerometer con-
tinuously for at least 7 days. Of those days, we excluded
invalid days, i.e. those with less of 10 h of data per day.
In addition, we excluded participants with less than 3
days of data [34–36]. Therefore, 2189 participants had
valid data, defined as 3 or more days of data with more
than 10 h recorded each day. Out of 2189 participants
with accelerometer, 662 had additional data on body
composition obtained from Dual-energy X-ray absorpti-
ometry (DXA) measurements. All participants provided
written informed consent. The study’s protocol was ap-
proved by the Research Ethic Committees from all
recruiting centers according to the ethical standards of
the Declaration of Helsinki. The trial was registered at
the International Standard Randomized Controlled Trial
(ISRCTN: http://www.isrctn.com/ISRCTN89898870).
Exposure assessment
Participants were asked to wear an accelerometer on
their non-dominant wrist (GENEActiv, ActivInsights
Ltd., Kimbolton, United Kingdom) continuously for 7
days. The GENEActiv is a triaxial accelerometer with a
dynamic range of ±8 g, where g is equal to the Earth’s
gravitational pull. The GENEActiv was set to capture
and store accelerations at a sampling frequency of 40 Hz
[37]. As these activity counts are time and date stamped,
detailed data on the time, volume, and intensity of
movements can be derived [38].
Wrist-worn 3-axial accelerometers do not permit to
distinguish standing from sitting or reclining postures, a
fact that has conditioned the use of the term inactivity
(include all postures) instead of sedentarism (only sitting
or reclining postures) in the current study.
Data extracted from the GENEActiv (all in bouts of at
least 1min) was clustered as: inactive time (cut-off inten-
sity level used was < 40mg) for those behaviours during
waking hours equivalent to < 1.5 Metabolic Equivalent
Task, METs; LPA (cut-off intensity level used was ≥40mg
and < 100mg) equivalent to 1.5–3 METs; MVPA (cut-off
intensity level used was ≥100mg) equivalent to > 3 METs;
and time in bed (time between going to bed and leaving,
calculated using a validated heuristic algorithm from accel-
erometer raw data unaided by a sleep diary) [37, 39, 40].
For sensitivity analyses we used accelerometer estimated
data on sleep time (calculated from accumulated sustained
inactivity bouts (SIB) during time in bed, excluding short
wake periods (min/night). SIB are detected as the absence
of change in arm angle greater than 5 degrees for 5min or
more [41]); nevertheless, our main models are based on
time in bed data, given that this estimation has been vali-
dated when no information from sleep diaries is available.
Raw data files were managed on servers at the University
of Malaga and processed with R-package (R Core Team,
Vienna, Austria) using the open-source R-package GGIR,
version 1.2–5 (cran.rproject.org/web/packages/GGIR/index.
html). This open sources code has been validated in rela-
tion to self-calibrated functions [42].
Outcome assessment
Obesity
Obesity prevalence and obesity indicators were determined
based on anthropometric parameters. Anthropometric vari-
ables were measured by trained personnel according to
PREDIMED-Plus protocol [32]. Body weight (kg) and height
(cm) were measured in light clothing and without shoes
using calibrated scales and a wall-mounted stadiometer.
BMI was calculated by dividing the weight (kg) by height in
meters squared (m2). Obesity was defined as a BMI ≥30 kg/
m2, and overweight as a BMI ≥ 27 and < 30 kg/m2 (given the
inclusion criteria, all of our participants had a BMI ≥ 27
and < 40 kg/m2). Waist circumference (WC) was measured
at the middle point between the last rib and the iliac crest.
All anthropometric variables were determined in duplicate,
and the average of the two measurements was used.
Body composition
Baseline data on total and regional body composition was
measured using two types of DXA equipment belonging to
the third-generation scanners from GE Healthcare, Madi-
son – WI, connected with EnCore™ software, depending
on the availability of this material in the recruiting centers.
Total body fat mass (expressed as percentage of total body
mass), total body muscle mass (expressed as percentage of
total body mass) and Visceral Adipose Tissue (VAT) mass
(in kg) were measured. For VAT measures, scans were rea-
nalyzed using validated CoreScan software application [43].
These algorithms work through detection of the width of
the subcutaneous tissue layer on the lateral part of the
abdomen and the anterior-posterior thickness of the abdo-
men, by X-ray attenuation of the abdominal cavity in the
android region. DXA scans were performed by trained
operators following standard protocol and subject position-
ing provided by the manufacturer. The DXA was phantom
calibrated daily according to manufacturer guidelines.
Biochemical analyses and clinical determinations
Blood samples were collected after 12 h of overnight fast
and biochemical analysis were performed on fasting plasma
to determine glucose, glycated hemoglobin (HbA1c), low-
density (LDL)-cholesterol, high-density lipoprotein (HDL)-
cholesterol and triglycerides concentrations using enzymatic
methods. Blood pressure was measured three times with a
validated semiautomatic oscillometer (Omron HEM-705CP,
the Netherlands) at 5, 10 and 15min of rest whilst in a
seated position.
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Metabolic syndrome
MetS was defined according to the International Dia-
betes Federation and the American Heart Association
and National Heart, Lung and Blood Institute [33], as
having at least 3 of the following components: abdom-
inal obesity for European individuals (WC ≥88 cm in
women and ≥ 102 cm in men), hypertriglyceridemia
(≥150 mg/dL) or drug treatment for high plasma trigly-
ceride concentration, low HDL (< 50mg/dL in women
and < 40 mg/dL in men), high blood pressure (systolic
blood pressure (SBP) ≥130 mmHg or diastolic blood
pressure (DBP) ≥85mmHg) or antihypertensive drug
treatment, or high fasting glucose (≥100 mg/dL) or drug
treatment for T2D. The presence of MetS was part of
the inclusions criteria.
Type 2 diabetes
T2D was defined as meeting any of the following cri-
teria: self-reported diabetes at inclusion or baseline,
HbA1c ≥ 6.5% or use of antidiabetic medication at base-
line, such as insulin, metformin (in case of diagnosed
diabetes or Hba1c ≥ 6.5%), and other medication for
diabetes.
Covariate assessment
Baseline data on sex, age, smoking habits, educational level,
erMedDiet, marital status, medical conditions and medica-
tion use have been evaluated using self-reported question-
naires. Smoking habits was categorized as current, former
and never smoker; educational level was categorized as
higher education/technician, secondary education and not-
completed primary education/primary education; marital
status was categorized as married and not married, which
included single/separated/divorced/widow (er). Adherence
to an energy-restricted Mediterranean diet was measured
using a 17-items ErMedDiet score (score range, 0–17;
higher scores indicate greater adherence). This score is a
modified version of the validated 14-item MEDAS (Medi-
terranean diet Adherence Screener) used in the PRE-
DIMED study [44]. We also used data on objectively
measured muscle strength. Lower-limb muscle strength
was determined at baseline using previously validated in
community-dwelling older subjects 30s-chair-stand test
[45]. This test consists of counting the number of stand-sit
on a chair cycles within 30 s. Medication use, including
medication for high blood pressure, for high cholesterol, in-
sulin, metformin, and other medications for diabetes treat-
ment, were self-reported by participants at baseline and
checked against medical records.
Statistical analysis
Participants were classified in three categories (tertiles),
depending on the inactive time in hours accumulated in
one day. Tertile 1 (T1) included those participants
accumulating less than 7.6 h/day of inactive time (low
time spent with inactive behaviours). Tertile 2 (T2) in-
cluded those participants who spent between 7.6 and
9.3 h/day inactive (moderate time spent with inactive be-
haviours). And tertile 3 (T3) included those participants
accumulating between 9.3 and 15.1 h/day inactive (high
time spent with inactive behaviours).
Descriptive characteristics were summarized as means
and standard deviations (SDs) or as numbers and per-
centages (%). One-way analysis of variance (ANOVA)
and Chi-square tests (χ2) were used to assess differences
across tertiles of inactive time in hours/day for continu-
ous and categorical variables respectively.
First generalized additive models were applied to ascer-
tain about the linearity in the association between our
exposures and outcomes. Given that there was no evidence
of departure from linearly, multivariate linear regression
analyses were used to estimate the β-coefficients and 95%
confidence intervals (CIs) for the associations between
inactive time (continuous variable: bouts of 30min; cat-
egorical variable: sex-specific tertiles) and BMI, WC, body
fat, body muscle mass, VAT, HbA1c, glucose, HDL, LDL,
triglycerides, SBP and DBP. Our models were adjusted by
the minimally sufficient adjustment set of covariables,
determined using Directed Acyclic Graphs (DAGs) imple-
mented in DAGitty software [46] available free on www.
dagitty.net. The DAGs were built by identifying all known
factors related to inactive time or our outcomes. Therefore
our main models were adjusted for age, sex, educational
level, marital status, erMedDiet, MVPA and smoking.
Logistic regression models were used to assess the as-
sociation between categories of inactive time (tertiles)
and the prevalence of the MetS’s components, as well as
prevalence of obesity and T2D. Prevalence ratios (PR)
were calculated using the odds ratios (OR) obtained with
logistic regression model. PR permits to assess the true
ratios of prevalence in this sample, given the high preva-
lence of MetS, obesity and T2D in the present popula-
tion, to avoid an overestimation of the risk. PR were
calculated as [(1-P0) + (P0*OR)] (P0 is the prevalence in
the reference category) [47].
Linear regression modelling using an isotemporal
substitution was used to quantify the associations of re-
placing 30 min of inactive time for 30 min of time in
bed, LPA or MVPA on cardio-metabolic risk markers.
Isotemporal substitution has been recommended for use
in observational research using time-based measures of
physical activity [30]. Prior to running the models, all
activity patterns (time in bed, inactive time, LPA and
MVPA) were divided by a constant of 30, which was
considered as an unit of time equivalent to 30 min (ac-
cording to the PA guidelines [21, 22, 48]). Consequently,
every unit increase represents exchanges of 30 min per
day of any of these behaviours. To perform the
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isotemporal substitution models, a variable representing
the total accelerometer wear time was constructed by
adding up time in bed, inactive time, LPA and MVPA.
This variable of wear time was entered simultaneously in
the analysis with time in bed, LPA and MVPA. The
resulting regression coefficient represents the association
of re-allocating a unit of inactive time to a unit of time
in bed, LPA and MVPA. Finally, the model was adjusted
for age, sex, educational level, marital status, erMedDiet
and smoking. Analyses follow published guideline for
isotemporal substitution [31].
Sensitivity analyses were also conducted. Multiple ad-
justed linear and logistic regression models were ad-
justed for LPA, instead of MVPA, given that LPA is the
most prevalent type of PA in our population and in
older adults in general, and some studies had found
beneficial effects of LPA on health [4, 5, 26, 27, 49]. In
addition, multiple adjusted linear regression models were
further adjusted for WC when assessing as an outcome:
HbA1c, glucose, HDL, LDL, triglycerides, SBP and DBP.
Finally, linear regression models shown in Table 2 were
also adjusted for wear time, and results were consistent
(data not shown).
In order to test whether the results of the isotemporal
replacement models remained similar when using a
proxy measure of sleep time, sleep time and time in bed
were included in the analysis conjointly with the covari-
ables mentioned above.
Statistical analyses were performed using Stata v15.0
program. P-values <0.05 were deemed as statistically sig-
nificant. All analyses were conducted with data from
database PREDIMED-Plus with date 2019-March-12.
Results
Table 1 presents a comparison of participants’ characteristics
among the three categories of inactive time. Participants in
the upper tertile (T3) of inactivity were significantly older
and had a higher BMI, WC, total body fat, VAT, HbA1c, glu-
cose and triglycerides concentrations, and lower levels of
total body muscle mass, and HDL cholesterol. Participants in
T3 presented significantly higher prevalence of T2D (38%)
and obesity (78%) compared to the other groups, and re-
ported higher consumption of medication for the treatment
of diabetes. Those in the most inactive category accumulated
the least amount of time in bed, total PA, LPA and MVPA,
and accumulated less repeats in the chair-stand test (all p
values < 0.001). Lastly, the highest prevalence of smokers was
found among those in T3 (p < 0.001).
Table 2 shows the β-coefficients (95% CIs) for the as-
sociations between total inactive time, (both per 30-min
bouts and in tertiles) and anthropometric measurements,
body composition, biochemical parameters and blood
pressure. Higher inactive time was associated with a
worse adiposity and cardio-metabolic profile, including
statistically significant higher BMI, WC, total body fat,
VAT, HbAc1, glucose, triglycerides and DBP, and lower
total body muscle mass and HDL cholesterol level.
Table 3 shows the prevalence ratios for obesity, T2D
and the MetS’s components by categories of inactive
time. Those in the most inactive category (T3) showed
significantly higher obesity prevalence (p for trend =
0.014), significantly higher triglycerides (p = 0.005), and
higher number of MetS components, ≥4 components (p
for tend = 0.051) and 5 components (p for tend = 0.054),
compared to those with less inactive time (T1).
Table 4 shows the β-coefficients (95% CIs) of the iso-
temporal substitution models. Figure 1 shows the same
isotemporal substitution models but outcome variables
had been standardized as z-scores to aid visualization of
results. Isotemporal substitution of 30 min a day of in-
active time with equivalent time in bed was associated
with lower BMI, WC and HbA1c (all p-values < 0.05);
reallocating 30min of inactive time per day with LPA or
MVPA (i.e., decreasing inactive time at the expense of
increasing LPA or MVPA time) was associated with
lower BMI, WC, total body fat, VAT, HbA1c, glucose,
triglycerides, and higher total body muscle mass and
HDL (all p-values < 0.05). Estimates of association were
larger in all variables when replacing 30min a day of in-
active time by the equal amount of time in MVPA than
when replacing it by LPA or time in bed.
No significant changes were observed when performing
sensitivity analyses adjusting linear and logistic regression
models for LPA instead of MVPA (See Additional file 1:
Table S1 and Table S3), or for WC (See Additional file 1:
Table S2). When running the isotemporal replacement
models with sleep time instead of time in bed results also
remained similar (See Additional file 1: Table S4).
Discussion
Results from this cross-sectional study show that time
spent inactive was associated with a number of cardio-
metabolic risk factors in a sample of older adults, inde-
pendent of PA levels. Overall, this study highlights that
replacing 30min a day of inactive time with an equal
amount of MVPA, LPA and time in bed resulted in a
significantly improved cardio-metabolic profile in men
and women with the MetS.
The results from this study show that inactive time
worsens the metabolic profile in an aging population with
high cardio-metabolic risk, increasing the chances of car-
diovascular events. This is similar to other studies where it
has been found that high levels of inactivity, including
sitting time, are associated with higher rates of obesity,
triglycerides and MetS [50, 51] and premature mortality
and diabetes [51, 52] across different populations.
Isotemporal substitution analyses have public health
implications [4, 9, 13, 23, 25, 28, 29, 31]. Comparative
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Table 1 Baseline characteristics of the study population across categories of inactive time measured by accelerometer
Tertiles of inactive time (h/day)a
Total n All T1 n = 735 T2 n = 729 T3 n = 725 P - value
Age, years 2189 65.0 (4.95) 64.1 (4.77) 65.2 (4.94) 65.8 (4.98) < 0.001
Women, n (%) 2189 1032 (47.1) 345 (46.9) 343 (47.1) 344 (47.5) 0.979
Anthropometric measures
BMI (kg/m2) 2189 32.6 (3.46) 32.2 (3.29) 32.4 (3.37) 33.2 (3.63) < 0.001
Waist circumference (cm) 2189 107 (9.54) 106 (9.41) 107 (9.20) 109 (9.78) < 0.001
DXA Body composition
Total body fat (%) 662 40.8 (6.98) 39.4 (6.83) 40.7 (6.84) 42.3 (6.98) < 0.001
VAT (kg) 651 2.27 (0.90) 2.12 (0.85) 2.32 (0.90) 2.38 (0.93) 0.006
Total body muscle mass (%) 662 56.1 (6.62) 57.4 (6.50) 56.2 (6.50) 54.7 (6.61) < 0.001
Clinical parameters
HbA1c (%) 2009 6.15 (0.87) 6.08 (0.81) 6.12 (0.79) 6.26 (0.99) < 0.001
Glucose (mg/dL) 2164 114 (29.5) 113 (27.9) 113 (27.8) 117 (32.4) 0.035
HDL (mg/dL) 2173 47.8 (11.9) 49.1 (12.0) 47.7 (11.9) 46.6 (11.6) < 0.001
LDL (mg/dL) 2127 121 (46.5) 122 (31.9) 122 (51.0) 119 (53.7) 0.459
Triglycerides (mg/dL) 2178 152 (78.9) 141 (74.9) 151 (71.4) 165 (87.7) < 0.001
SBP (mmHg) 2175 140 (17.4) 140 (17.0) 141 (17.3) 140 (18.0) 0.293
DBP (mmHg) 2175 80.3 (10.1) 80.6 (9.88) 80.0 (9.92) 80.2 (10.4) 0.430
Diabetes prevalence, n (%) 2189 749 (34.2) 229 (31.2) 246 (33.7) 274 (37.8) 0.027
Obesity prevalence, n (%) 2189 1610 (73.6) 519 (70.6) 528 (72.4) 563 (77.7) 0.007
Metabolic Syndrome
High blood pressure, n (%) 2189 1611 (73.6) 534 (72.7) 542 (74.3) 535 (73.8) 0.755
High triglycerides, n (%) 2178 901 (41.4) 244 (33.4) 305 (42.0) 352 (48.9) < 0.001
Low HDL cholesterol, n (%) 2173 888 (40.9) 263 (36.0) 307 (42.3) 318 (44.3) 0.004
High glucose, n (%) 2189 1686 (77.0) 566 (77.0) 561 (77.0) 559 (77.1) 0.998
High waist circumference, n (%) 2189 2098 (95.8) 706 (96.1) 693 (95.1) 699 (96.4) 0.408
Physical activity behavioursb
Time in bed (h/day) 2189 8.06 (1.29) 8.28 (1.25) 8.23 (1.21) 7.68 (1.33) < 0.001
Inactive time (h/day) 2189 8.30 (1.98) 6.25 (0.90) 8.21 (0.56) 10.5 (1.31) < 0.001
LPA (h/day) 2189 2.54 (1.07) 3.45 (0.99) 2.45 (0.74) 1.72 (0.63) < 0.001
MVPA (h/day) 2187 0.67 (0.54) 0.93 (0.59) 0.66 (0.49) 0.43 (0.40) < 0.001
Total PA (h/day) 2187 3.22 (1.33) 4.38 (1.22) 3.11 (0.84) 2.15 (0.78) < 0.001
Chair test 30s (repeats) 2189 13.3 (5.01) 13.8 (5.12) 13.3 (5.00) 12.7 (4.83) < 0.001
Sociodemographic/lifestyle data
Smoking habits, n (%) 2181 < 0.001
Never 942 (43.2) 328 (44.8) 329 (45.4) 285 (39.4)
Current 251 (11.5) 61 (8.3) 75 (10.3) 115 (15.9)
Former 988 (45.3) 343 (46.9) 321 (44.3) 324 (44.7)
Educational level, n (%) 2171 < 0.001
Higher education/technician 474 (21.8) 113 (15.5) 176 (24.3) 185 (25.8)
Secondary education 610 (28.1) 210 (28.8) 198 (27.4) 202 (28.1)
Primary education/illiterate 1087 (50.1) 406 (55.7) 350 (48.3) 331 (46.1)
Alcohol intake (g/day) 2187 11.4 (15.4) 11.7 (15.5) 11.0 (14.7) 11.5 (16.1) 0.649
Energy intake (kcal/day) 2187 2407 (633) 2444 (640) 2413 (629) 2364 (628) 0.051
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Table 1 Baseline characteristics of the study population across categories of inactive time measured by accelerometer (Continued)
Tertiles of inactive time (h/day)a
Total n All T1 n = 735 T2 n = 729 T3 n = 725 P - value
MedDiet score (17 points) 2189 8.56 (2.70) 8.64 (2.75) 8.61 (2.63) 8.42 (2.71) 0.243
Marital status 2179 0.004
Not Married 546 (25.1) 161 (22.0) 174 (23.9) 211 (29.3)
Married 1633 (74.9) 570 (78.0) 553 (76.1) 510 (70.7)
Medication use for
High blood pressure 2189 1700 (77.7) 554 (75.4) 563 (77.2) 583 (80.4) 0.065
Cholesterol 2189 1159 (53.0) 378 (51.4) 384 (52.7) 397 (54.8) 0.437
Insulin 2189 111 (5.07) 36 (4.90) 35 (4.80) 40 (5.52) 0.796
Metformin 2189 544 (24.9) 160 (21.8) 184 (25.2) 200 (27.6) 0.035
Other medications for diabetes 2189 514 (23.5) 151 (20.5) 171 (23.5) 192 (26.5) 0.028
Data shown is mean (SD), unless otherwise specified; Abbreviations: BMI body mass index, VAT visceral adipose tissue, SBP systolic blood pressure, DBP diastolic
blood pressure, LDL low density lipoproteins, HDL high density lipoproteins, HbA1c glycated haemoglobin, PA physical activity, LPA light physical activity, MVPA
moderate-to-vigorous physical activity, MedDiet Mediterranean diet. a T1, Men (min 3.79 / max 7.6), Women (min 2.64 / max 7.15). T2 Men (min 7.61 / 9.34max);
Women (min 7.16 / 8.73max). T3, Men (min 9.35 / 17.2 max), Women (min 8.74/ 15.15max). Tertiles were calculated using the total sample of 2189, and the
sample size shown corresponds to the distribution of these 2189 individuals within tertiles; the sample size within tertiles varied for outcome variables with
different total sample size. Sample sizes in tertiles of body composition variables determined by DXA were: T1, n = 225; T2, n = 219; T3, n = 218. bData shown of
time in bed, physical activity and inactive time has been recorded by accelerometer. High waist circumference was defined has a circumference ≥ 120 cm in men
and ≥ 88 cm in women. High glucose was defined as ≥110 mg/dl of glucose in blood or antidiabetic treatment with metformin or insulin. High levels of
triglycerides was defined as ≥150 mg/dl of blood. Low levels of HDL cholesterol was defined as ≤40 mg/dl in men and ≤ 50mg/dl in women. Obesity was defined
with a BMI ≥30 kg/m2. Hypertension was defined with a SBP ≥90 mmHg and a SBP ≥140 mmHg. It was considered diabetes if the participant has a previous
diagnosis of diabetes, with a HbA1c (%) ≥6.5, or with the use of medication for diabetes treatment as insulin and metformin
Table 2 Associations of total inactive time with adiposity indicators and cardio-metabolic risk factors
Tertiles of inactive time (h/day)a p for trend Continuous
(per 30 min/d of
inactive time)
p-value
Outcome T1 n = 735 T2 n = 729 T3 n = 725
Anthropometric measures
BMI (kg/m2) 0 (ref.) 0.22 (−0.14;0.58) 0.90 (0.52;1.29) < 0.001 0.11 (0.06;0.15) < 0.001
Waist circumference (cm) 0 (ref.) −0.05 (− 0.99;0.89) 1.97 (0.96;2.97) < 0.001 0.26 (0.15;0.37) < 0.001
Body Composition
Total body fat (%) 0 (ref.) 0.69 (−0.14;1.53) 1.41 (0.50;2.32) 0.002 0.17 (0.07;0.27) 0.001
VAT (Kg) 0 (ref.) 0.16 (0.00;0.31) 0.23 (0.06;0.39) 0.013 0.03 (0.01;0.05) 0.002
Total body muscle mass (%) 0 (ref.) −0.66 (−1.46;0.14) −1.30 (−2.17;-0.44) 0.003 − 0.16 (− 0.25;-0.06) 0.002
Clinical Parameters
HbA1c (%) 0 (ref.) 0.01 (−0.09;0.10) 0.11 (0.01;0.21) 0.032 0.02 (0.01;0.03) < 0.001
Glucose (mg/dL) 0 (ref.) 0.08 (−3.06;3.22) 2.68 (−0.68;6.05) 0.116 0.47 (0.11;0.83) 0.010
HDL (mg/dL) 0 (ref.) −1.02 (−2.19;0.15) − 1.64 (− 2.89;-0.39) 0.010 −0.20 (− 0.34;-0.07) 0.003
LDL (mg/dL) 0 (ref.) 1.16 (−3.87;6.19) − 1.23 (−6.63;4.17) 0.652 −0.19 (− 0.76;0.39) 0.526
Triglycerides (mg/dL) 0 (ref.) 8.58 (0.25;16.9) 20.0 (11.0;28.9) < 0.001 2.15 (1.20;3.11) < 0.001
SBP (mmHg) 0 (ref.) 1.43 (−0.41;3.27) 0.34 (−1.63;2.32) 0.740 −0.00 (− 0.21;0.21) 0.981
DBP (mmHg) 0 (ref.) 0.02 (−1.03;1.06) 0.74 (−0.38;1.86) 0.195 0.14 (0.02;0.26) 0.022
Values shown are β (95% CI). Abbreviations: BMI body mass index, VAT visceral adipose tissue, HbA1c glycated haemoglobin, HDL high density lipoprotein, LDL low
density lipoprotein, SBP systolic blood pressure, DBP; diastolic blood pressure. Linear regression models were used to assess the association between inactive time
and each cardiometabolic risk outcomes, adjusting for age, sex, education level, marital status, erMedDiet, moderate-vigorous physical activity and smoking. a T1,
Men (min 3.79 / max 7.6), Women (min 2.64 / max 7.15). T2 Men (min 7.61 / 9.34max); Women (min 7.16 / 8.73max). T3, Men (min 9.35 / 17.2 max), Women (min
8.74/ 15.15max). Tertiles were calculated using the total sample of 2189, and the sample size shown corresponds to the distribution of these 2189 individuals
within tertiles; the sample size within tertiles varied for outcome variables with different total sample size. Sample sizes in tertiles of body composition variables
determined by DXA were: T1, n = 225; T2, n = 219; T3, n = 218
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Table 3 Prevalence Ratio of clinical and metabolic syndrome parameters according to tertiles of inactive time
Tertiles of inactive time (h/day)a p for
trendOutcome T1 n = 735 T2 n = 729 T3 n = 725
Obesity prevalence 1 (ref.) 1.02 (0.95;1.09) 1.09 (1.02;1.15) 0.014
Diabetes prevalence 1 (ref.) 1.05 (0.89;1.21) 1.14 (0.96;1.32) 0.125
Metabolic Syndrome Components
High blood pressure 1 (ref.) 0.97 (0.93;1.00) 1.01 (0.98;1.03) 0.580
High triglycerides 1 (ref.) 1.11 (1.01;1.21) 1.16 (1.05;1.26) 0.005
Low HDL cholesterol 1 (ref.) 1.08 (0.96;1.22) 1.05 (0.90;1.19) 0.533
High glucose 1 (ref.) 0.99 (0.93;1.05) 0.99 (0.92;1.05) 0.674
High waist circumference 1 (ref.) 0.99 (0.96;1.01) 1.00 (0.97;1.02) 0.954
≥ 4 components metabolic syndrome 1 (ref.) 1.09 (0.97;1.21) 1.13 (1.00;1.25) 0.051
5 components metabolic syndrome 1 (ref.) 1.08 (0.82;1.40) 1.30 (0.99;1.67) 0.054
Values shown are prevalence ratios (95% CI). Abbreviations: HDL high-density lipoprotein. Logistic regression models were adjusted for age, sex, educational level,
marital status, erMedDiet, moderate-vigorous physical activity and smoking status. Tertiles were calculated using the total sample of 2189, and the sample size
shown corresponds to the distribution of these 2189 individuals within tertiles; the sample size within tertiles varied for outcome variables with different total
sample size
aT1, Men (min 3.79 / max 7.6), Women (min 2.64 / max 7.15). T2 Men (min 7.61 / 9.34max); Women (min 7.16 / 8.73max). T3, Men (min 9.35 / 17.2 max), Women
(min 8.74/ 15.15max). Tertiles were calculated using the total sample of 2189, and the sample size shown corresponds to the distribution of these 2189 individuals
within tertiles.
Table 4 Isotemporal substitution of inactive time (30 min/day) with time in bed and physical activity on cardio-metabolic risk
Outcome Inactive time with time in bed p-value Inactive time with LPA p-value Inactive time with MVPA p-value
Anthropometric measures
BMI (kg/m2) −0.12 (−0.18;-0.05) < 0.001 −0.19 (− 0.27;-0.11) < 0.001 − 0.40 (− 0.55;-0.25) < 0.001
Waist circumference (cm) − 0.29 (− 0.46;-0.13) 0.001 −0.42 (− 0.62;-0.21) < 0.001 −1.11 (−1.49;-0.72) < 0.001
Body composition
Total body fat (%) −0.07 (− 0.21;0.08) 0.391 −0.43 (− 0.62;-0.25) < 0.001 −0.69 (− 1.03;-0.34) < 0.001
VAT (Kg) − 0.03 (− 0.05;0.00) 0.052 −0.06 (− 0.09;-0.03) 0.001 −0.06 (− 0.12;0.01) 0.075
Total body muscle mass (%) 0.05 (−0.09;0.20) 0.465 0.40 (0.22;0.56) < 0.001 0.62 (0.29;0.95) < 0.001
Clinical parameters
HbA1c (%) −0.02 (− 0.04;-0.01) 0.006 − 0.03 (− 0.05;-0.01) 0.002 −0.08 (− 0.12;-0.05) < 0.001
Glucose (mg/dL) − 0.09 (− 0.64;0.45) 0.736 −1.05 (− 1.73;-0.38) 0.002 −2.15 (−3.44;-0.87) 0.001
HDL (mg/dL) 0.11 (− 0.10;0.31) 0.306 0.27 (0.01;0.52) 0.039 1.15 (0.67;1.63) < 0.001
LDL (mg/dL) 0.30 (−0.58;1.19) 0.502 0.34 (−0.75;1.43) 0.538 1.43 (−0.63;3.48) 0.174
Triglycerides (mg/dL) −0.89 (−2.35;0.58) 0.235 −1.98 (−3.78;-0.17) 0.032 −9.40 (−12.8;-5.99) < 0.001
SBP (mmHg) 0.09 (−0.24;0.41) 0.597 −0.02 (− 0.42;0.38) 0.906 0.35 (− 0.41;1.11) 0.363
DBP (mmHg) −0.07 (− 0.26;0.11) 0.431 − 0.08 (− 0.30;0.15) 0.505 0.36 (− 0.07;0.79) 0.105
Values shown are β (95% CI). These represent the change in outcome variables when substituting 30min/day of inactive time with time in bed and physical
activity. Abbreviations: LPA light physical activity, MVPA moderate-vigorous physical activity, BMI body mass index, VAT visceral adipose tissue, HbA1c glycated
haemoglobin, HDL high density lipoprotein, LDL low-density lipoprotein, SBP; systolic blood pressure, DBP diastolic blood pressure. Linear regression models were
used to assess isotemporal substitution of inactive time with: time in bed, light PA and MVPA, adjusting for age, sex, educational level, marital status, erMedDiet,
smoking and total wear time
aT1, Men (min 3.79 / max 7.6), Women (min 2.64 / max 7.15). T2 Men (min 7.61 / 9.34max); Women (min 7.16 / 8.73max). T3, Men (min 9.35 / 17.2 max), Women
(min 8.74/ 15.15max). Tertiles were calculated using the total sample of 2189, and the sample size shown corresponds to the distribution of these 2189 individuals
within tertiles
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research in older adults is limited, especially in a popula-
tion with chronic conditions, such as MetS [25]. Thus,
the present results are in line with previous research
conducted in adults (18–79 years) [4, 9, 13, 23, 25],
which shows the beneficial effects of exchanging an
unit of time spent inactive with equal amounts of PA
or sleep on cardio-metabolic risk factors, including
obesity and lipid profile. This study shows that re-
placing inactive time with any other behaviors has
beneficial effects on cardio-metabolic risk, and these
benefits increase proportionally. For instance, re-
placing 30 min/d of inactive time with 30 min/d of
time in bed was associated with a lower WC of −
0.26 cm, whereas replacing this amount of inactive
time with LPA resulted in a WC of − 0.45 cm and
with MVPA in a WC of − 1.08 cm.
Previous studies in adults have highlighted the benefits
of replacing inactive time with MVPA, with the greatest
benefits on improved BMI [9], T2D [9, 23], triglycerides,
HbA1c [23] and glucose. Similarly, this study shows that
interchanging 30min of time inactive by MVPA was sig-
nificantly associated with improvements in BMI, WC, body
fat, muscle mass, HbA1c, glucose, HDL and triglycerides.
Furthermore, the present study shows that health benefits
are also attained when time inactive is replaced by LPA or
time in bed, with improvements on: BMI, WC, body fat,
VAT, muscle mass, HbA1c, glucose, HDL and triglycerides
(LPA); and BMI, WC and HbA1c (time in bed). This is of
interest, as research on this area continuous to mount,
however findings remain ambiguous [4, 9, 10, 13, 23–25,
23] and although there are some studies in adult popula-
tion [4, 25, 28, 29], few research has been conducted in
older adults [23, 26] and, as far as we know, none in indi-
viduals with overweight/obesity and metabolic syndrome.
Given the prevalence of MetS, and the prevalence of
an population aging worldwide, effective and sustain-
able long term actions are needed. Understanding the
beneficial effects of substituting time inactive with dif-
ferent activity levels and sleep in high risk and aging
populations is of importance as it will help defining
future tailored health interventions. Multicomponent
interventions to increase PA and decrease inactive time,
using a multidisciplinary approach are recommended.
According to our results, the promotion of MVPA
would be of most benefit, however in older adults de-
signing health interventions focused on LPA and sleep
might be more appropriate. Interventions focused on
LPA and sleep might result more feasible, appealing
and might help improve attrition and sustainability in
the long term, as they will not need continuous supervi-
sion and are easy to implement at home or care homes.
A marked strength of this study was the use of a large
cohort of older men and women, with overweight/obesity
and MetS. It is important to highlight that only objective
and validated measurements were used for this study for
both exposure and outcome variables. This reduces any
potential bias or measurement error and increases the op-
portunities for comparison across the literature. In terms
Fig. 1 Isotemporal substitution of inactive time (30 min/day) with time in bed and physical activity on standardized cardio-metabolic risk. Values
shown are β (95% CI). These represent the change in outcome variables (z-scores) when substituting 30 min per day of inactive time with time in
bed and physical activity. Abbreviations: LPA: light physical activity; MVPA: moderate-vigorous physical activity; BMI: body mass index; VAT: visceral
adipose tissue; HbA1c: glycated haemoglobin; HDL: high density lipoprotein; LDL: low-density lipoprotein; SBP: systolic blood pressure; DBP:
diastolic blood pressure. Linear regression models were used to assess isotemporal substitution of inactive time with time in bed, light PA and
MVPA, adjusting for age, sex, educational level, marital status, erMedDiet, and smoking.*indicates p value < 0.05
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of limitations, the cross-sectional design prevents the as-
sessment of causality. Given that exposure and outcome
variables were measured simultaneously, we cannot rule
out reverse causation, i.e. our outcomes, such as obesity,
may have preceded inactivity, and not the other way
round. In addition, due to its cross-sectional study design,
the isotemporal replacement model used in this study is
not based on actual replacements of one activity for an-
other and should be interpreted at the population level;
longitudinal studies are necessary to confirm the results
obtained in this study. Selection of older subjects with
overweight/obesity and MetS for the study cohort limits
extrapolation of findings to other populations, including
younger, leaner or healthier subjects. Moreover, this study
was limited to Caucasians, hence the associations found
may not be applicable to other ethnic groups. Thus, repli-
cating this research in different ethnic groups with differ-
ent lifestyles and fat distribution would be of interest.
Methodological limitations of differentiating between
sitting, standing are also important to consider. The wrist-
worn 3-axial accelerometers used in this study quantify
time spent in different intensities of activity based on spe-
cific count thresholds. This method works reasonably well
for identifying inactive, LPA and MVPA but it is limited
in its capacity to distinguish between standing and reclin-
ing postures. Thus, throughout this paper we refer to “in-
activity” (activities of < 1.5 METs during day-time) and
not “sedentarism” (meaning activities of < 1.5 METs/day
in seated or reclining positions). Another limitation is the
use of the cutoff intensity level points to cluster data as in-
active, LPA or MVPA time. Cut points are normally popu-
lation and protocol specific, limiting the possibility of
comparison across studies and populations [35]. Finally,
although we used validated algorithms to estimate time in
bed from accelerometer data without the use of sleep
diaries, sleep time estimates were less accurate, which
prevented us from using sleep time in the main analyses.
This issue has been overcame by using several sophisti-
cated analysis to assess the complex inter-relationships
between different lifestyle behaviours in relation to cardio-
metabolic risk factors.
Conclusion
These results add to the growing literature using Isotem-
poral Replacement methods and it is one of the few fo-
cused on older adults with the metabolic syndrome.
Results from this cross-sectional study indicate that re-
placing inactive time with any PA and time in bed was as-
sociated with improved cardio-metabolic factors in older
adults with overweight or obesity and the MetS. Our find-
ings support the notion that PA and inactive time are both
linked with health outcomes and that both behaviors
should be included in public health guidelines. Future
intervention studies are needed to confirm causality.
Tailored health intervention research with a focus on
sleep, LPA and MVPA are recommended.
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